Line of Treatment for Typhoid (Enteric) Fever

1. General Principles

2. Antibiotic Regimens

• Fluoroquinolones (e.g., ciprofloxacin) - historically first-line, but now limited by widespread resistance, particularly strains from the Indian subcontinent and parts of Africa with reduced ciprofloxacin susceptibility (MIC >0.125 µg/mL). Harrison's now advises fluoroquinolones should no longer be used empirically in these regions.
• Azithromycin (oral) - effective for uncomplicated disease, including many multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains; relapse rates appear lower with azithromycin than with fluoroquinolones or ceftriaxone (Yamada's Textbook of Gastroenterology).
• Cefixime (oral) - alternative, but associated with higher rates of clinical failure and slower defervescence compared to fluoroquinolones.

• Ceftriaxone (IV third-generation cephalosporin) - preferred for hospitalized or complicated cases and where resistance is a concern.
• A 2022 systematic review of 27 RCTs (cited in Harrison's) found no significant difference in treatment failure, relapse, or adverse events between ceftriaxone, fluoroquinolones, and azithromycin.

• Chloramphenicol, amoxicillin, or TMP-SMX - traditional regimens, doses roughly: chloramphenicol 50-75 mg/kg/day, amoxicillin 75-100 mg/kg/day, TMP-SMX 8-40 mg/kg/day, generally for 14-21 days (Park's Textbook of Preventive and Social Medicine).

• Resistant to ceftriaxone, ampicillin, ciprofloxacin, and TMP-SMX; susceptible only to azithromycin and carbapenems (e.g., meropenem) - Red Book 2021, Harrison's.

3. Severe/Complicated Disease

• In severe typhoid with delirium, obtundation, stupor, coma, or shock (enteric encephalopathy), adjunctive high-dose dexamethasone has classically been added to antibiotic therapy to reduce mortality (per Harrison's and standard ID teaching), though this is used less commonly now with modern antibiotics.
• Supportive care: IV fluids/electrolyte correction, antipyretics, nutritional support, and monitoring for complications (GI bleeding, perforation, myocarditis).

4. Surgical Management (Intestinal Perforation)

• Intensive care management
• Resuscitation plus IV antibiotics
• Laparotomy (choice of procedure depends on findings - primary repair, resection, or exteriorization in very ill patients)
• Systematic search for additional perforations
• Consideration of leaving the wound open for delayed secondary closure in critically ill patients
• Prognosis is better with a shorter diagnosis-to-operation interval.

5. Chronic Carrier State

6. Prevention (Adjunct to Treatment Strategy)

Recent Evidence Check

• A 2024 systematic review of RCTs (PMID: 39623850) evaluated oral azithromycin versus other antimicrobials across all age groups, generally supporting azithromycin's efficacy comparable to or better than fluoroquinolones/ceftriaxone/chloramphenicol, consistent with the textbook guidance above.
• No recent systematic review contradicts the textbook-based approach; growing antimicrobial resistance (especially fluoroquinolone and the Pakistan XDR clone) reinforces azithromycin, ceftriaxone, and carbapenems as increasingly important options over fluoroquinolones.